Does anyone have a somewhat closer contact to the company?
I was wondering, I sent a mail at the beginning of the week (Monday early, early morning) about two items:
a) The SSL certificate for the pisces micro website expired (it's the top most link with yellow background from the main Oncosec.com website and directs to https://www.piscesclinicaltrial.com/). It's still not repaired and patients that might want to inform themselves about the trial will see a big red warning in their browser.
b) I asked if the statistical assumptions behind the changed trial design has been made public anywhere. One should note that you cannot simply use the standard formulas* because we have done an "unblinded sample size re-estimation", i.e. peeked at the results.
I did not receive a reply yet and the https://www.piscesclinicaltrial.com/ website still has an invalid certificate. So I wonder, has anyone spoken with the company recently? How fast does their investor relations react?